Skip to cookie consent Skip to main content

Mass General Brigham’s Chief Data Science Officer Named to TIME 100 AI List

TIME magazine has named Dr. Keith Dreyer, chief data science officer and vice chairman of radiology at Mass General Brigham, to its first-ever Time 100 AI list, highlighting 100 individuals advancing major conversations about how artificial intelligence is reshaping the world. 

The list features leaders, policymakers, artists, and entrepreneurs across a variety of fields and from countries around the world. 

See the full list here and the profile of Dr. Dreyer here.

As the chief data science officer, Dr. Dreyer is the leader of the global Mass General Brigham AI business to develop and scale AI-enabled solutions that solve real-world clinical problems both across the Mass General Brigham system and for leading industry collaborators.

“It is an honor to be included on the inaugural TIME 100 AI list alongside others who are shaping the future of AI across industries,” said Dr. Dreyer. “AI in healthcare holds tremendous promise and potential for our many stakeholders — from patients and caregivers to providers and administrators — by enabling novel insights that support clinical impact. I’m committed to improving healthcare delivery and operations through the development and productization of AI-enabled solutions in a manner that maximizes societal good.”

Since its inception in 2016, Mass General Brigham’s AI business has provided the bridge between academic research and product development, with a full complement of services required to translate research and innovation into clinical practice. Mass General Brigham’s current initiatives encompass AI/ML-enabled solutions in diagnostics, hospital operations, and other specialty services. The team, composed of clinicians, data scientists, product managers, technical project managers, software engineers, and regulatory science experts works across clinical applications, smart devices, and infrastructure. Mass General Brigham’s AI work has access to the expertise of the system’s world-renowned clinical investigators and data scientists to address complex problems in health care delivery, operations, and care coordination. It houses end-to-end product development infrastructure and expertise for regulatory and validation strategy and clinical deployment through its Digital CRO. 

“We are thrilled Dr. Dreyer has been recognized by TIME for his dedication to shaping healthcare AI at our health system and beyond,” said Aaron Gerber, MD, MBA, senior vice president, Diversified Businesses, Mass General Brigham. “The impact of his work spans benefits to patients and providers across the globe, and we’re excited to continue to create and develop new products and offerings that pioneer the future of medicine.”

Dr. Dreyer is also an associate professor of radiology at Harvard Medical School, the chief science officer for the American College of Radiology’s Data Science Institute and has held numerous board, chair, advisory, and committee positions with numerous national and international medical societies and global healthcare corporations. He has authored hundreds of scientific papers, presentations, chapters, articles, and books and has lectured worldwide on artificial intelligence in healthcare, clinical data science, cognitive computing, clinical decision support, clinical language understudying, digital imaging standards, and implications of technology on the quality of health care and payment reform initiatives. 

Media contact

Mass General Brigham Media Relations

About Mass General Brigham

Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit